Topic: MERCK
130 results were found.
Germany's Merck invests 300 mln euros in life science facility - April 26, 2024
Merck Q1 EPS $1.87 - April 26, 2024
Merck KgaA profit fell 15.1 percent - March 8, 2024
Merck Animal Health to acquire Elanco’s aqua business for $1.3 billion in cash - February 6, 2024
Merck Q4 loss $1.23 billion - February 2, 2024
Merck to acquire Harpoon Therapeutics in $680 million deal - January 9, 2024
Merck to acquire Caraway Therapeutics for up to $610 million - November 24, 2023
Merck KGaA Q3 profit declined 20 percent - November 10, 2023
Merck Q3 EPS $1.86 - October 27, 2023
Merck to pay up to $22b in cancer drug deal with Daiichi Sankyo - October 20, 2023
Moderna and Merck mRNA cancer vaccine cut risk of death or recurrence of most deadly skin cancer by 44% - April 17, 2023
Merck to buy Prometheus Biosciences for about $11 billion - April 17, 2023
Merck/Ridgeback COVID-19 pill rejected in Europe - February 24, 2023
Study: Merck COVID-19 pill linked to virus mutations - February 2, 2023
Merck's Keytruda shows survival benefit, meets main goal of gastric cancer trial - November 23, 2022
Merck sales increased by 16.8% - November 10, 2022
Merck’s Vaxneuvance vaccine indication to include infants, children and adolescents - October 26, 2022
Merck opts to jointly develop cancer vaccine with Moderna - October 13, 2022
Merck to initiate new Phase 3 clinical program with lower dose of Islatravir with Doravirine for HIV-1 - September 23, 2022
Merck KGaA Q2 profit rises - August 4, 2022
Merck KGaA Q1 profit rises - May 12, 2022
Merck Q1 earnings $4.31 billion - April 29, 2022
Merck FY21 net sales up 13.8% - March 3, 2022
Merck Q4 net income $4.58 billion - February 4, 2022
Britain says 6,000 more people needed for trial of Merck COVID pill - January 25, 2022
Japan approves Merck COVID-19 pill - December 25, 2021
Merck acquires Chord Therapeutics - December 22, 2021
U.S. government to purchase 1.4 million additional courses of Merck COVID-19 pill - November 10, 2021
Japan to buy 1.6 mln courses of Merck's COVID 19 pill - November 10, 2021
Merck Q3 net income $4.57 billion - October 28, 2021
EMA starts rolling review of Merck's COVID-19 pill - October 25, 2021
Malaysia buys 150,000 courses of Merck's COVID-19 pill - October 7, 2021
Merck's COVID pill cuts hospitalisations by half - October 1, 2021
Merck to acquire Acceleron Pharma for $11.5 billion - September 30, 2021
Merck begins late-stage trial of experimental COVID-19 drug - September 2, 2021
Merck net reported sales increased 18.2% - August 5, 2021
Commission fines Sigma-Aldrich €7.5 million for providing misleading information during Merck takeover investigation - May 10, 2021
Whistleblower: FDA didn't react to blood, urine and feces in Merck facility - April 3, 2021
Merck: Organon will acquire Alydia Health - March 31, 2021
Merck appoints Frank Clyburn to lead Human Health - March 17, 2021
Merck KGaA FY20 profit up - March 5, 2021
Merck to the rescue of Johnson & Johnson COVID-19 vaccine - March 3, 2021
Merck buys Poultry Sense, monitoring solutions company from UK - March 1, 2021
Merck to buy Pandion Therapeutics in $1.85 billion deal - February 25, 2021
4D Pharma, Merck and Pfizer ink trial collaboration for carcinoma drug - February 8, 2021
Kenneth C. Frazier to retire as Merck CEO - February 5, 2021
Merck discontinues development of COVID-19 vaccine candidates - January 25, 2021
Merck signs $356 million U.S. supply deal for its experimental coronavirus treatment - December 23, 2020
Merck to acquire VelosBio - November 6, 2020
Merck to acquire Themis - May 27, 2020
Merck net sales increased - May 14, 2020
Merck net sales rose 8.9% - March 5, 2020
Merck Q4 sales increased 8 percent, plans to spin off women businesses - February 5, 2020
Merck establishes $2.5 billion strategic oncology collaboration with Taiho and Astex - January 7, 2020
Merck expands in Wilson County, N.C., will invest $57 million, employ 55 - December 6, 2019
Merck KGaA Q3 net profit edges up - November 14, 2019
Merck Q3 pharmaceutical sales $11.1 billion - October 29, 2019
Merck completes 5.8 billion euros acquisition of Versum Materials - October 7, 2019
U.S. Department of Health giving $23 million to Merck to make Ebola vaccine - August 22, 2019
Merck Q2 net income soared 90.8% - August 8, 2019
Merck's global sales jump 12% in Q2 - July 30, 2019
Merck to buy Tilos Therapeutics for up to $773 million - June 10, 2019
Merck to acquire Peloton Therapeutics for $1.05 billion - May 21, 2019
Merck KgaA Q1 profit declines - May 14, 2019
Merck to invest $1 billion in Rockingham County, Va. - May 7, 2019
Merck Q1 sales $10.8 billion - April 30, 2019
Merck KGaA agrees $6.5 billion takeover of Versum Materials - April 12, 2019
Merck KGaA gets Versum's support for sweetened $6.5 billion offer - April 8, 2019
Merck goes hostile with $5.9 billion takeover offer for Versum - March 26, 2019
Merck KGaA net income grew 29.5 percent - March 7, 2019
Merck KGaA to Versum: Your own financial advisor supports our takeover bid - March 6, 2019
Versum Materials rejects Merck KGaA's 5.9 billion offer - March 2, 2019
GlaxoSmithKline and Merck KGaA strike deal worth up to $4 billion - February 6, 2019
Merck Q3 net income $1.83 billion - February 2, 2019
Merck to acquire Antelliq Group for EUR2.1 billion plus debt - December 14, 2018
Merck Q3 sales rose 6.6% - November 14, 2018
EU OK with $3.9 billion P&G deal for Merck's consumer health business - August 28, 2018
Merck KGaA Q2 net income down 42% - August 10, 2018
Merck Q2 non-GAAP EPS $1.06 - July 28, 2018
Merck KGaA Q1 profit after tax down 34.8 percent - May 15, 2018
Procter & Gamble to acquire Merck unit in $4.2 billion deal - April 19, 2018
Merck KgaA FY17 net profit climbs, EBITDA down - March 8, 2018
Merck to buy Viralytics for $394 million - February 21, 2018
Merck posts advance in Q4 profit - February 2, 2018
Merck slips to loss in Q3 - October 27, 2017
Merck considers sale of consumer health business - September 5, 2017
Merck KgaA Q2 profit climbs - August 3, 2017
Merck Q2 worldwide sales $9.9 billion - July 28, 2017
AstraZeneca, Merck in collaboration on cancer drug, will receive up to $8.5 billion - July 27, 2017
EU charges Merck KGaA, GE, Canon, companies risk hefty fines - July 6, 2017
Merck Q1 profit dips, adjusted EBITDA rises - May 18, 2017
Merck Q1 Non-GAAP EPS $0.88 - May 2, 2017
Merck Q4 net income climbed 113.8 percent - March 9, 2017
Merck to take $2.9bn pre-tax impairment charge on HCV drug - February 24, 2017
Merck posts 21 percent increase in Q4 profit - February 2, 2017
Eli Lilly & Co. expands immuno-oncology collaboration with Merck - January 11, 2017
Merck EBITDA pre exceptionals rose sharply by 24.3% - November 15, 2016
Merck & Co posts 10% increase in Q3 profit - October 25, 2016
Sanofi files U.S. suit against Merck over patents - September 19, 2016
Merck & Co Q2 profit climbed 75 percent - July 29, 2016
Merck to acquire Afferent Pharmaceuticals in $1.25 billion deal - June 11, 2016
Thanks to Sigma-Aldrich, Merck increases sales, earnings - May 19, 2016
Merck to invest $168 million in Rockingham County, Va. - March 29, 2016
Gilead Sciences to pay Merck $200 million for infringing two patents - March 25, 2016
Merck pays $20 million for new cancer drug from Harvard - March 22, 2016
Sanat Chattopadhyay named president of Merck manufacturing division - March 9, 2016
Sanofi Pasteur and Merck end their joint work on vaccines - March 8, 2016
Merck Q4 worldwide sales down 3% to $10.2 billion - February 3, 2016
Merck solves Vioxx class action, will pay $830 million - January 15, 2016
Sigma-Aldrich and Merck KGaA have EU approval for acquisition - November 11, 2015
Merck Q3 worldwide sales $10.1 billion, 5% down - October 27, 2015
Stefan Oschmann appointed new executive board chairman of Merck - October 14, 2015
ANI Pharmaceuticals to buy two products from Merck for $75+ million - September 22, 2015
Sigma-Aldrich good to be bought by Merck KGaA - August 11, 2015
Merck Ebola vaccine candidate has 100 percent efficacy - August 1, 2015
Merck Q2 non-GAAP EPS was $0.86, GAAP EPS was $0.24 - July 29, 2015
Allergan buys rights to Merck's migraine drugs - July 8, 2015
Acquisition of Sigma-Aldrich by Merck KGaA good to go - June 17, 2015
Merck Q1 worldwide sales $9.4 billion, down 8 percent - April 29, 2015
Merck names EVP, global public policy and population health - December 11, 2014
Robert M. Davis to succeed Peter N. Kellogg as Merck CFO - March 31, 2014
Merck appoints CIO - September 2, 2013
Roger M. Perlmutter president of Merck Research Laboratories - March 8, 2013
Merck KGaA: Elmar Schnee leaves, Stefan Oschmann successor - December 13, 2010
Merck elects Kenneth C. Frazier as next CEO - December 1, 2010
Merck: Kenneth C. Frazier new chief executive officer - November 30, 2010
Merck announces senior management appointments - April 29, 2010
Merck: Bridgette P. Heller new EVP and president - February 16, 2010
Merck: Michael Rosenblatt EVP, chief medical officer - December 16, 2009
Three directors for newly-combined Merck - September 4, 2009